Researchers Develop New Drug Paradigm, Liquid Crystal Pharmaceuticals

The American Cancer Society estimates that nearly 1.5 million new cases of cancerwill be diagnosed this year. This crisis has caused the National Cancer Institute to establish a goal of eliminating suffering and death due to cancer by the year 2015. Kent State University, Summa Health System and IC-MedTech Inc. have taken steps toward that goal. Their collaborative efforts have yielded an innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases.

MORE ON THIS TOPIC